Overall rank by patents
#658
Across all tracked assignees
USPTO PatentsView assignee record - 681 granted patents across 104 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
Bayer holds 681 US patents across 104 technology areas, rank #658 of 50,000 tracked assignees.
Bayer Healthcare Llc has been granted 681 US utility patents between 2015 and 2025, placing Bayer Healthcare Llc at rank #658 across all assignees tracked by PlainPatent. This portfolio spans 104 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.2 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Bayer Healthcare Llc is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Bayer sits between GM Cruise Holdings Llc (685 patents, rank #654) and Kone Corporation (677 patents, rank #662) - the closest US assignees by grant volume. The composite Innovation Score of 66.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 391 grants, compared with 290 in the 2015–2019 window, a +35% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Bayer Healthcare Llc's 15.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Bayer Healthcare Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
GM Cruise Holdings LLC
685 patents
The Brigham and Women's Hospital, Inc.
685 patents
Yale University
685 patents
TIANMA MICROELECTRONICS CO., LTD.
684 patents
M.S. Technologies, L.L.C.
681 patents
BAYER HEALTHCARE LLC
681 patents
TOPCON CORPORATION
680 patents
SHINKO ELECTRIC INDUSTRIES CO., LTD.
678 patents
Kone Corporation
677 patents
What this shows Bayer holds 681 patents at rank #658, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #658 in granted patent volume.
Other assignees with the most granted patents in Bayer's primary technology class.
Bayer's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
66 Top 1% higher than 99% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 57 | 8.4% |
| 2016 | 55 | 8.1% |
| 2017 | 62 | 9.1% |
| 2018 | 63 | 9.3% |
| 2019 | 53 | 7.8% |
| 2020 | 38 | 5.6% |
| 2021 | 63 | 9.3% |
| 2022 | 70 | 10.3% |
| 2023 | 67 | 9.8% |
| 2024 | 85 | 12.5% |
| 2025 | 68 | 10.0% |
Top 15 of 104 technology areas
Overall rank by patents
#658
Across all tracked assignees
66.3 out of 100
How to use this portfolio
Bayer's 681 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.